Sample Name
Sample Code
Sample Name
Sample Code
Sample Name
Sample Code
4
BIDU-SW
09888
5
JD HEALTH
06618
| (Q6)Jun 30, 2025 | (FY)Dec 31, 2024 | (Q6)Jun 30, 2024 | (FY)Dec 31, 2023 | (Q6)Jun 30, 2023 | (FY)Dec 31, 2022 | (Q6)Jun 30, 2022 | (FY)Dec 31, 2021 | (Q6)Jun 30, 2021 | (FY)Dec 31, 2020 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Cash flow from operating activities | ||||||||||
| Earning before tax | ---- | -434.23%-3.5B | ---- | -57.24%1.05B | ---- | -20.28%2.45B | ---- | 23.63%3.08B | ---- | 46.82%2.49B |
| Profit adjustment | ||||||||||
| Interest (income) - adjustment | ---- | 45.00%-60.96M | ---- | -10.09%-110.83M | ---- | -3,897.82%-100.67M | ---- | 88.15%-2.52M | ---- | ---21.24M |
| Dividend (income)- adjustment | ---- | ---- | ---- | ---921K | ---- | ---- | ---- | ---- | ---- | ---- |
| Attributable subsidiary (profit) loss | ---- | 60.65%-17.68M | ---- | 20.31%-44.94M | ---- | -78.83%-56.39M | ---- | 49.35%-31.53M | ---- | -175.07%-62.26M |
| Impairment and provisions: | ---- | 376.80%4.61B | ---- | 107.77%967.43M | ---- | 190.69%465.62M | ---- | 64.45%160.18M | ---- | 696.06%97.41M |
| -Impairment of goodwill | ---- | -42.46%246.21M | ---- | --427.89M | ---- | ---- | ---- | ---- | ---- | ---- |
| -Other impairments and provisions | ---- | 709.30%4.37B | ---- | 15.87%539.54M | ---- | 190.69%465.62M | ---- | 64.45%160.18M | ---- | 696.06%97.41M |
| Revaluation surplus: | ---- | 154.47%13.6M | ---- | -419.56%-24.97M | ---- | 122.67%7.82M | ---- | -32.78%-34.47M | ---- | -2,779.36%-25.96M |
| -Fair value of investment properties (increase) | ---- | 2.62%10.37M | ---- | 143.40%10.1M | ---- | -3,811.09%-23.27M | ---- | ---595K | ---- | ---- |
| -Other fair value changes | ---- | 109.23%3.24M | ---- | -212.83%-35.07M | ---- | 191.76%31.09M | ---- | -30.49%-33.88M | ---- | -2,779.36%-25.96M |
| Asset sale loss (gain): | ---- | 470.97%216.28M | ---- | 73.28%-58.3M | ---- | -192.91%-218.18M | ---- | -855.14%-74.49M | ---- | 152.06%9.86M |
| -Loss (gain) from sale of subsidiary company | ---- | 724.35%103.99M | ---- | -1,380.17%-16.66M | ---- | 105.90%1.3M | ---- | -278.09%-22.04M | ---- | ---5.83M |
| -Loss (gain) on sale of property, machinery and equipment | ---- | 126.35%6.9M | ---- | -898.99%-26.18M | ---- | -47.98%3.28M | ---- | 26.66%6.3M | ---- | 1,220.27%4.97M |
| -Loss (gain) from selling other assets | ---- | 781.58%105.39M | ---- | 93.06%-15.46M | ---- | -279.18%-222.76M | ---- | -648.07%-58.75M | ---- | 157.93%10.72M |
| Depreciation and amortization: | ---- | -5.82%369.36M | ---- | 11.66%392.18M | ---- | 24.49%351.22M | ---- | 55.57%282.13M | ---- | 102.56%181.35M |
| -Amortization of intangible assets | ---- | -6.52%189.8M | ---- | -4.71%203.03M | ---- | 22.78%213.06M | ---- | 50.78%173.53M | ---- | 137.62%115.09M |
| Financial expense | ---- | 43.24%28.83M | ---- | 8.42%20.13M | ---- | -25.41%18.57M | ---- | -38.33%24.89M | ---- | 146.87%40.36M |
| Exchange Loss (gain) | ---- | 125.14%1.35M | ---- | -206.36%-5.39M | ---- | 139.95%5.06M | ---- | 303.47%2.11M | ---- | ---1.04M |
| Special items | ---- | ---- | ---- | -74.06%10.37M | ---- | --39.99M | ---- | ---- | ---- | ---- |
| Operating profit before the change of operating capital | ---- | -24.37%1.66B | ---- | -26.03%2.19B | ---- | -12.84%2.96B | ---- | 25.71%3.4B | ---- | 52.23%2.71B |
| Change of operating capital | ||||||||||
| Inventory (increase) decrease | ---- | -57.72%3.58M | ---- | 215.59%8.47M | ---- | -147.91%-7.33M | ---- | 496.71%15.29M | ---- | -196.38%-3.86M |
| Accounts receivable (increase)decrease | ---- | 29.86%-1.07B | ---- | 63.32%-1.53B | ---- | -633.31%-4.17B | ---- | -49.99%-568.6M | ---- | -22.24%-379.1M |
| Accounts payable increase (decrease) | ---- | -66.68%206.22M | ---- | -34.37%618.85M | ---- | 498.93%942.98M | ---- | -76.61%157.44M | ---- | 138.74%673.12M |
| Special items for working capital changes | ---- | -57.78%76.56M | ---- | 323.66%181.35M | ---- | -73.16%42.81M | ---- | 40.10%159.49M | ---- | -29.68%113.85M |
| Cash from business operations | 320.06%77.64M | -40.75%872.38M | -106.46%-35.28M | 751.05%1.47B | 157.44%546.31M | -107.14%-226.16M | -173.12%-951.14M | 1.78%3.17B | -5.77%1.3B | 62.37%3.11B |
| Other taxs | 42.04%-194.25M | 6.55%-443.63M | 10.88%-335.14M | 32.90%-474.74M | 21.73%-376.07M | -35.82%-707.55M | -41.90%-480.49M | -6.37%-520.96M | -20.44%-338.62M | -55.30%-489.75M |
| Net cash from operations | 68.52%-116.61M | -57.02%428.75M | -317.58%-370.42M | 206.85%997.64M | 111.89%170.24M | -135.31%-933.7M | -248.80%-1.43B | 0.92%2.64B | -12.47%962.11M | 63.77%2.62B |
| Cash flow from investment activities | ||||||||||
| Interest received - investment | 88.29%13.91M | -81.58%11.57M | -39.68%7.39M | 54.59%62.78M | 9.90%12.24M | 860.02%40.61M | -45.34%11.14M | -82.60%4.23M | -31.21%20.38M | 31.38%24.31M |
| Dividend received - investment | -49.99%3.62M | 826.60%25.88M | 94.83%7.24M | --2.79M | --3.72M | ---- | ---- | -35.08%18.04M | -68.98%6.13M | 321.22%27.78M |
| Loan receivable (increase) decrease | -620.61%-663.46M | 27.68%-325.5M | -20.32%-92.07M | -368.49%-450.08M | -122.54%-76.52M | 174.13%167.64M | 312.19%339.5M | -181.51%-226.13M | -366.50%-160M | 4,480.96%277.42M |
| Decrease in deposits (increase) | ---- | ---- | ---- | ---- | -99.55%14.8M | 200.00%3.3B | 69,563.27%3.3B | -14,773.14%-3.3B | -195.15%-4.75M | -362.56%-22.19M |
| Sale of fixed assets | -41.23%2.96M | -1.38%62.58M | -38.68%5.04M | 440.15%63.45M | 13.54%8.22M | -61.82%11.75M | 1,440.21%7.24M | 1,464.11%30.77M | 58.78%470K | -38.63%1.97M |
| Purchase of fixed assets | 38.41%-32.6M | 49.45%-108.53M | -5.46%-52.92M | 9.49%-214.68M | 44.98%-50.18M | -184.33%-237.19M | -339.83%-91.2M | -53.98%-83.42M | -75.39%-20.74M | -269.51%-54.18M |
| Selling intangible assets | ---- | ---- | -99.29%10K | --104K | --1.41M | ---- | ---- | --128K | ---- | ---- |
| Purchase of intangible assets | 50.47%-366K | -52.91%-1.63M | -39.43%-739K | 59.76%-1.06M | -960.00%-530K | 33.37%-2.64M | -28.21%-50K | 54.97%-3.97M | 93.81%-39K | -115.59%-8.81M |
| Sale of subsidiaries | 97.54%13.57M | 475.88%7.19M | --6.87M | 100.12%1.25M | ---- | -849.85%-1B | -846.51%-1B | -51.35%133.38M | -55.39%133.97M | 94,431.03%274.14M |
| Acquisition of subsidiaries | ---- | 363.66%8.22M | 147.79%8.22M | -95.18%1.77M | -146.73%-17.19M | 105.06%36.79M | 133.51%36.79M | 20.70%-726.57M | 83.64%-109.78M | -186.64%-916.21M |
| Recovery of cash from investments | 187.76%1.48B | -64.80%812.59M | -46.93%513.91M | 16.04%2.31B | -12.78%968.43M | -36.76%1.99B | -20.39%1.11B | -16.36%3.15B | -39.82%1.39B | 121.78%3.76B |
| Cash on investment | 25.72%-507.1M | 50.00%-1.06B | 28.10%-682.72M | 31.81%-2.13B | 70.57%-949.54M | -0.32%-3.12B | -107.48%-3.23B | 26.95%-3.11B | 15.92%-1.56B | -34.69%-4.26B |
| Other items in the investment business | ---- | ---- | ---- | ---- | -85.18%100M | ---- | --674.92M | ---290.97M | ---- | ---- |
| Net cash from investment operations | 210.57%309.36M | -61.78%-571.78M | -1,982.39%-279.78M | -129.82%-353.42M | -98.72%14.86M | 126.87%1.18B | 494.07%1.16B | -393.26%-4.41B | -247.39%-294.88M | 49.63%-894.13M |
| Net cash before financing | 129.65%192.76M | -122.20%-143.03M | -451.26%-650.2M | 156.36%644.22M | 168.66%185.11M | 114.23%251.29M | -140.41%-269.6M | -202.29%-1.77B | -48.65%667.23M | 1,086.62%1.73B |
| Cash flow from financing activities | ||||||||||
| New borrowing | -74.67%66.8M | 42.52%493M | 112.71%263.69M | 109.26%345.91M | 8.25%123.97M | 50.36%165.3M | 9.63%114.52M | 95.87%109.94M | 503.84%104.46M | 42.19%56.13M |
| Refund | -80.45%-847.68M | -320.46%-647.89M | -490.17%-469.76M | -93.84%-154.09M | -21.85%-79.6M | 77.65%-79.49M | 71.88%-65.32M | -105.82%-355.74M | -1,609.48%-232.28M | -430.40%-172.84M |
| Issuing shares | ---- | ---- | ---- | ---- | ---- | ---- | ---- | --2.68B | --2.68B | ---- |
| Interest paid - financing | -9.61%-16.32M | -93.42%-25.86M | -56.96%-14.89M | -307.03%-13.37M | -270.84%-9.49M | -126.48%-3.28M | 12.79%-2.56M | 90.93%-1.45M | -49.41%-2.93M | -640.23%-15.99M |
| Dividends paid - financing | 45.05%-62.76M | -45.23%-283.51M | -12.38%-114.22M | 73.68%-195.22M | -63.65%-101.63M | 15.23%-741.73M | 26.63%-62.1M | -21.65%-874.97M | 86.31%-84.64M | -79.78%-719.27M |
| Absorb investment income | ---- | -119.31%-4.59M | ---- | 343.86%23.74M | 158.05%13.8M | -32.62%5.35M | 46.55%5.35M | --7.94M | --3.65M | ---- |
| Issuance expenses and redemption of securities expenses | ---3.9M | ---- | ---- | ---- | ---- | ---- | ---- | ---- | ---- | ---- |
| Other items of the financing business | -90.05%-51.03M | 68.17%-106.29M | 81.87%-26.85M | -161.08%-333.95M | -58.96%-148.11M | 69.24%-127.91M | ---93.17M | ---415.85M | ---- | ---- |
| Net cash from financing operations | -143.21%-934.86M | -64.34%-614.64M | -71.02%-384.39M | 55.35%-374M | -76.19%-224.76M | -175.95%-837.58M | -105.21%-127.57M | 225.87%1.1B | 492.25%2.45B | -105.45%-876.11M |
| Effect of rate | -276.29%-365K | -125.14%-1.35M | -195.10%-97K | 207.76%5.39M | -97.09%102K | -50.24%-5M | -84.52%3.51M | -528.73%-3.33M | 8,580.84%22.66M | -178.37%-529K |
| Net Cash | 28.27%-742.1M | -380.39%-757.66M | -2,509.09%-1.03B | 146.09%270.22M | 90.02%-39.65M | 11.58%-586.29M | -112.74%-397.17M | -177.99%-663.11M | 362.27%3.12B | 241.38%850.25M |
| Begining period cash | -18.68%3.32B | 7.25%4.07B | 7.36%4.08B | -13.47%3.8B | -13.47%3.8B | -13.18%4.39B | -13.18%4.39B | 20.20%5.06B | 20.20%5.06B | -12.49%4.21B |
| Cash at the end | -15.42%2.57B | -18.63%3.32B | -19.03%3.04B | 7.25%4.07B | -5.93%3.76B | -13.47%3.8B | -51.24%4B | -13.18%4.39B | 67.92%8.2B | 20.20%5.06B |
| Cash balance analysis | ||||||||||
| Currency Unit | CNY | CNY | CNY | CNY | CNY | CNY | CNY | CNY | CNY | CNY |
| Accounting Standards | HKAS | HKAS | HKAS | HKAS | HKAS | HKAS | HKAS | HKAS | HKAS | HKAS |
| Audit Opinions | -- | Unqualified Opinion | -- | Unqualified Opinion | -- | Unqualified Opinion | -- | Unqualified Opinion | -- | Unqualified Opinion |
| Auditor | -- | Grant Thornton (Hong Kong) Certified Public Accountants Limited | -- | Zhitong (Hong Kong) Certified Public Accountants Limited | -- | Zhitong (Hong Kong) Certified Public Accountants Limited | -- | PricewaterhouseCoopers | -- | PricewaterhouseCoopers |
FY: Financial Year. Refers to the 10-K file disclosed by the listed company to the SEC.
Q: Quarter. Refers to the 10-Q file disclosed by the listed company to the SEC. Q1, Q2, Q3, and Q4 are quarterly reports each with a span of 3 months; Q6 and Q9 are cumulative reports, with Q6 including 6 months and Q9 9 months.